Skip to main content
Clinical Trials/NCT06111027
NCT06111027
Completed
Phase 1

Usability of Laryngeal Vibro-tactile Stimulation as a Non-invasive Treatment for the Voice Disorder Spasmodic Dysphonia

University of Minnesota1 site in 1 country40 target enrollmentSeptember 20, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Spasmodic Dysphonia
Sponsor
University of Minnesota
Enrollment
40
Locations
1
Primary Endpoint
Perceived voice effort
Status
Completed
Last Updated
last year

Overview

Brief Summary

The general aim of the study is to provide evidence for usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (SD). This work addresses a clinical need to develop alternative or auxiliary treatments for a rare voice disorder with very limited treatment options. Successful completion of the proposed work will be an important step in advancing laryngeal VTS as a therapeutic intervention for improving voice symptoms in SD.

Registry
clinicaltrials.gov
Start Date
September 20, 2023
End Date
October 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of spasmodic dysphonia (laryngeal dystonia) for a minimum of 6 months with documented symptom relief after Botox injection.
  • Diagnosis is made by a voice disorder specialist.

Exclusion Criteria

  • Regular intake of benzodiazepines
  • Cognitive impairment: score \< 27 on Mini-mental state examination
  • Identifies with a neurological or musculoskeletal impairment affecting speech motor function. These impairments may include a form of: Dyskinesia, Dystonia, Essential Tremor, Huntington's Disease, Multiple System Atrophy, Muscle Tension Dysphonia, Parkinsonism, Progressive Supranuclear Palsy, Spasticity, Intracranial Neoplasm (brain tumor), Spinal Neoplasm, Cerebrovascular Accident (Stroke), Mild Traumatic Brain Injury, Intracranial Hemorrhage, Multiple Sclerosis

Outcomes

Primary Outcomes

Perceived voice effort

Time Frame: 8 weeks

Participants will rate their perceived effort level of vocalization on an ordinal scale of 0 to 10 (0 being with no effort and 10 being with maximal effort). The recordings will provide subjective impression of treatment.

Secondary Outcomes

  • The duration of voice break(8 weeks)
  • The number of voice breaks(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials